Roche said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer ...

Eating a balanced diet can lower your cancer risk and improve your overall health. Replace refined grains, added sugars, and highly processed foods with whole grains, beans, vegetables, and fruits.

A study published in The BMJ linked skipping first and subsequent mammograms to a higher chance of dying from breast cancer.

Hundreds of studies, including gold-standard clinical trials, challenge Health Secretary Robert F. Kennedy Jr.’s claim that ...

A major cross-border investigation has uncovered how a sperm donor carrying an undetected cancer-causing mutation fathered at ...

Roche Holding AG’s experimental pill reduced the risk of an invasive return of a form of breast cancer in a study that underscores the drug’s blockbuster potential. Patients adding the medicine, ...

The study, published this week in the Annals of Internal Medicine, suggests that GLP-1s have little to no effect on a ...

Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor degrader (SERD) to a 30% reduction in the risk of invasive disease ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy ...

Socioeconomic vulnerability and multiple medical comorbidities are risk factors for late-onset depression among long-term ...